J McDevitt1, H Comber2, P M Walsh2. 1. National Cancer Registry, 6800 Avenue 6000, Cork Airport Business Park, Cork, T12 CDF7, Ireland. j.mcdevitt@ncri.ie. 2. National Cancer Registry, 6800 Avenue 6000, Cork Airport Business Park, Cork, T12 CDF7, Ireland.
Abstract
BACKGROUND: The location and staging of a colorectal cancer (CRC) determine prognosis and choice of treatment. We examined the sub-site, sex, and stage distribution for CRC in Ireland for patients diagnosed in the period immediately prior to the implementation of a national screening programme. METHODS: Incident cases of CRC were abstracted from the National Cancer Registry for the period 1994-2012 (n = 38,912). Incidence proportions and 3-year cancer-related survival were calculated. RESULTS: The incidence of CRC during 2010-2012 averaged 1021 females and 1424 males per year. While the overall incidence rate of CRC was static during 1994-2012, this masked a significant increase in the rate of proximal colon tumours (+1.3 % per year), a decreases in the rate of tumours of overlapping/colon NOS (-2.2 % per year), and no change in the rates of cancers of the distal colon and rectosigmoid junction (RSJ)/rectum. Proximal tumours occurred more frequently in females (F vs. M, 38 vs. 29 %), in older persons and increased over time. Compared to distal colon tumours, proximal colon [RR risk ratio 1.08, 95 % CI (1.05, 1.10)] and RSJ/rectum tumours [RR 1.08 (1.05, 1.11)] were more likely to be diagnosed at late stage. The proportion of late-stage tumours increased steadily over five diagnosis periods [e.g., 1994-1997 (51 %) vs. 2010-2012 (57 %), RR 1.12 (1.08, 1.16)]. Cancer survival improved over four diagnosis periods. CONCLUSIONS: There was a distal-to-proximal shift and a trend towards diagnosis at late stage during 1994-2012. Some reversal of this trend is expected following the implementation of a national screening programme.
BACKGROUND: The location and staging of a colorectal cancer (CRC) determine prognosis and choice of treatment. We examined the sub-site, sex, and stage distribution for CRC in Ireland for patients diagnosed in the period immediately prior to the implementation of a national screening programme. METHODS: Incident cases of CRC were abstracted from the National Cancer Registry for the period 1994-2012 (n = 38,912). Incidence proportions and 3-year cancer-related survival were calculated. RESULTS: The incidence of CRC during 2010-2012 averaged 1021 females and 1424 males per year. While the overall incidence rate of CRC was static during 1994-2012, this masked a significant increase in the rate of proximal colon tumours (+1.3 % per year), a decreases in the rate of tumours of overlapping/colon NOS (-2.2 % per year), and no change in the rates of cancers of the distal colon and rectosigmoid junction (RSJ)/rectum. Proximal tumours occurred more frequently in females (F vs. M, 38 vs. 29 %), in older persons and increased over time. Compared to distal colon tumours, proximal colon [RR risk ratio 1.08, 95 % CI (1.05, 1.10)] and RSJ/rectum tumours [RR 1.08 (1.05, 1.11)] were more likely to be diagnosed at late stage. The proportion of late-stage tumours increased steadily over five diagnosis periods [e.g., 1994-1997 (51 %) vs. 2010-2012 (57 %), RR 1.12 (1.08, 1.16)]. Cancer survival improved over four diagnosis periods. CONCLUSIONS: There was a distal-to-proximal shift and a trend towards diagnosis at late stage during 1994-2012. Some reversal of this trend is expected following the implementation of a national screening programme.
Authors: Scott R Steele; Grace E Park; Eric K Johnson; Matthew J Martin; Alexander Stojadinovic; J A Maykel; Marlin W Causey Journal: Dis Colon Rectum Date: 2014-03 Impact factor: 4.585
Authors: Xiaocheng Wu; Vivien W Chen; Jim Martin; Steven Roffers; Frank D Groves; Catherine N Correa; Elizabeth Hamilton-Byrd; Ahmedin Jemal Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-07 Impact factor: 4.254
Authors: Jukes Namm; Melody Ng; Sharmila Roy-Chowdhury; John W Morgan; Sharon S Lum; Jan H Wong Journal: J Am Coll Surg Date: 2008-10-02 Impact factor: 6.113
Authors: J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray Journal: Eur J Cancer Date: 2013-02-26 Impact factor: 9.162
Authors: C Simillis; M Charalambides; A Mavrou; T Afxentiou; M P Powar; J Wheeler; R J Davies; N S Fearnhead Journal: Tech Coloproctol Date: 2022-09-22 Impact factor: 3.699
Authors: Norah Alsadhan; Alaa Almaiman; Mar Pujades-Rodriguez; Cathy Brennan; Farag Shuweihdi; Sultana A Alhurishi; Robert M West Journal: BMC Med Res Methodol Date: 2022-05-19 Impact factor: 4.612